August 20, 2017

Living with Afib — 2015 Atrial Fibrillation Patient Conference Video

The Living with Afib session at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference was presented by StopAfib.org Founder and CEO, Mellanie True Hills, who spoke about: • dedicating the conference to Judy Currier • knowing your stroke risk • autoimmune diseases and afib • common issues such as alcohol, […]

2013 Atrial Fibrillation Conference: Surgery & Left Atrial Appendage: William T. Brinkman, MD

Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference See all conference videos, and download the slides Here, Dr. William T. Brinkman discusses surgery for atrial fibrillation, including the concomitant maze, the classic Cox maze, the closed chest maze using the Dallas Lesion Set, and the new staged hybrid surgical ablation procedure. He also […]

What Are the Hidden Risks of Atrial Fibrillation?

During Atrial Fibrillation Awareness Month, StopAfib.org highlights a new video that explains the hidden afib risks. Learn more at: New StopAfib.org Video Explains the Hidden Afib Risks for Atrial Fibrillation Awareness Month

Atrial Fibrillation Awareness Month 2013

What you don’t know about atrial fibrillation could kill you, or a loved one! Atrial fibrillation (also called afib) is an irregular heartbeat (or heart rhythm), and is a major cause of strokes. Having afib increases your stroke risk by 500 percent. In addition, afib can lead to heart failure, dementia, and even Alzheimer’s disease. […]

ESC: Risk of stroke with or without atrial fibrillation

As reported at the European Society of Cardiology in Amsterdam, among patients with 0-2 stroke risk factors, those with atrial fibrillation had a three-fold risk of stroke over those who didn’t have afib. But that difference declined as the number of risk factors increased. The risk of stroke was high in those with 3 or […]

ESC: New Anticoagulant, Edoxaban, Safer Than Warfarin

We’re finally getting a glimpse into what to expect from edoxaban, the 4th new anticoagulant medication. At the European Society of Cardiology in Amsterdam, it was reported that edoxaban was safer–in other words, had less bleeding–than warfarin for those with deep vein thrombosis (blood clots in the legs) or pulmonary embolism (blood clots in the […]

ESC: Women with atrial fibrillation are undertreated by GPs

This confirms what we already knew… As reported today at the European Society of Cardiology in Amsterdam: “Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of […]

Watch the Team AFib webinar, AFib CARE: Creating A Role for Effective Teams, hosted by StopAfib.org

Team AFib presented a webinar, AFib CARE: Creating a Role for Effective Teams, in honor of National Atrial Fibrillation Awareness Month in 2011. A panel of healthcare providers and caregivers provided important information to help patients and caregivers work with members of their healthcare teams. If you didn’t get a chance to tune in to […]

Is It Time to Re-think Typical Atrial Fibrillation Treatment?

The wildly beating heart, fatigue and other debilitating symptoms are well known to the many millions of people impacted by atrial fibrillation. Some of those who have afib may have no outward symptoms, but are still at risk of serious and long-term damage to the heart.

Symptoms or not, rate control is the common treatment of choice, especially from those healthcare providers who are not well versed in afib treatment options. But this treatment sort of suspends afib patients in a “waiting and watching” middle ground, stuck in limbo with a diminished quality of life and an increased risk of stroke.

Stuck in the Middle: Afib Patients on Rate Control, from EP Lab Digest January, 2012

Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate […]